Friday turned out to be a nightmare for shareholders of Juno Therapeutics Inc (NASDAQ:JUNO) and T2 Biosystems Inc (NASDAQ:TTOO), as shares of both companies fell …
FBR analyst Edward White is weighing in on biotech firms Juno Therapeutics Inc (NASDAQ:JUNO) and Kite Pharma Inc (NASDAQ:KITE), as both stocks tumbled sharply today following FDA …
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is plummeting nearly 50% down to $4.55 after the FDA rejected the company’s New Drug Application for the second …
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today reported financial results …
Analysts weigh in on biotechnology stocks Juno Therapeutics Inc (NASDAQ:JUNO) and Cempra Inc (NASDAQ:CEMP). Both are bullish as Juno Therapeutics receives $50 million from collaboration partner Celgene, …
Juno Therapeutics, Inc. (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced that Celgene exercised its option to develop and commercialize the Juno CD19 program outside …
The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among …
Biotech earnings reports often give just as much insight into future plans as they do on past successes. Analysts from FBR & Co.
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today reported business highlights …
The biotech sector is taking center stage this week as several key players are scheduled to announced earnings. Investors and analysts are looking …
